NCT05768282View on ClinicalTrials.gov

Oral Prednisolone to Prevent Esophageal Stricture After RFA for Long-segment Esophageal Neoplasia

PHASE4RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 1, 2016

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2025

Conditions
Esophageal NeoplasmsEsophagus Stenosis
Interventions
DRUG

Oral prednisolone (30mg/day) for 28 days

Oral prednisolone was started at a dose of 30 mg/day on the third day after RFA, and continued for 4 weeks.

Trial Locations (1)

82445

RECRUITING

EDA Hospital, Kaohsiung City

All Listed Sponsors
lead

E-DA Hospital

OTHER